437 related articles for article (PubMed ID: 33970546)
21. Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study.
Zakerska-Banaszak O; Tomczak H; Gabryel M; Baturo A; Wolko L; Michalak M; Malinska N; Mankowska-Wierzbicka D; Eder P; Dobrowolska A; Slomski R; Skrzypczak-Zielinska M
Sci Rep; 2021 Jan; 11(1):2166. PubMed ID: 33495479
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
[TBL] [Abstract][Full Text] [Related]
23. Changes in intestinal microbiota and correlation with TLRs in ulcerative colitis in the coastal area of northern China.
Xu N; Bai X; Cao X; Yue W; Jiang W; Yu Z
Microb Pathog; 2021 Jan; 150():104707. PubMed ID: 33352216
[TBL] [Abstract][Full Text] [Related]
24. Regulatory effect of Garidisan on dysbiosis of the gut microbiota in the mouse model of ulcerative colitis induced by dextran sulfate sodium.
Pei LY; Ke YS; Zhao HH; Liu WZ; Wang L; Jia C; Shi MN; Fu QH; Cui J; Li SC
BMC Complement Altern Med; 2019 Nov; 19(1):329. PubMed ID: 31752807
[TBL] [Abstract][Full Text] [Related]
25. Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.
Reshef L; Kovacs A; Ofer A; Yahav L; Maharshak N; Keren N; Konikoff FM; Tulchinsky H; Gophna U; Dotan I
Gastroenterology; 2015 Sep; 149(3):718-27. PubMed ID: 26026389
[TBL] [Abstract][Full Text] [Related]
26. A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach.
Barberio B; Facchin S; Patuzzi I; Ford AC; Massimi D; Valle G; Sattin E; Simionati B; Bertazzo E; Zingone F; Savarino EV
Gut Microbes; 2022; 14(1):2028366. PubMed ID: 35129058
[TBL] [Abstract][Full Text] [Related]
27. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.
Kump PK; Gröchenig HP; Lackner S; Trajanoski S; Reicht G; Hoffmann KM; Deutschmann A; Wenzl HH; Petritsch W; Krejs GJ; Gorkiewicz G; Högenauer C
Inflamm Bowel Dis; 2013 Sep; 19(10):2155-65. PubMed ID: 23899544
[TBL] [Abstract][Full Text] [Related]
28. Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission.
Li Z; Li Z; Zhu L; Dai N; Sun G; Peng L; Wang X; Yang Y
Front Nutr; 2021; 8():778542. PubMed ID: 35028306
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
Del Chierico F; Cardile S; Baldelli V; Alterio T; Reddel S; Bramuzzo M; Knafelz D; Lega S; Bracci F; Torre G; Maggiore G; Putignani L
Inflamm Bowel Dis; 2024 Apr; 30(4):529-537. PubMed ID: 37696680
[TBL] [Abstract][Full Text] [Related]
30. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels.
Valcheva R; Koleva P; Martínez I; Walter J; Gänzle MG; Dieleman LA
Gut Microbes; 2019; 10(3):334-357. PubMed ID: 30395776
[TBL] [Abstract][Full Text] [Related]
31. The oral bacterial microbiota facilitates the stratification for ulcerative colitis patients with oral ulcers.
Xu J; Zhang Y; Fang XH; Liu Y; Huang YB; Ke ZL; Wang Y; Zhang YF; Zhang Y; Zhou JH; Su HT; Chen N; Liu YL
Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):99. PubMed ID: 37946238
[TBL] [Abstract][Full Text] [Related]
32. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
33. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
[TBL] [Abstract][Full Text] [Related]
34. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
[TBL] [Abstract][Full Text] [Related]
35. Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.
Sadeghi O; Milajerdi A; Siadat SD; Keshavarz SA; Sima AR; Vahedi H; Adibi P; Esmaillzadeh A
Trials; 2020 Jun; 21(1):565. PubMed ID: 32576228
[TBL] [Abstract][Full Text] [Related]
36. Intestinal Microbial Dysbiosis in Beagles Naturally Infected with Canine Parvovirus.
Park JS; Guevarra RB; Kim BR; Lee JH; Lee SH; Cho JH; Kim H; Cho JH; Song M; Lee JH; Isaacson RE; Song KH; Kim HB
J Microbiol Biotechnol; 2019 Sep; 29(9):1391-1400. PubMed ID: 31434168
[TBL] [Abstract][Full Text] [Related]
37. Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients.
Mar JS; LaMere BJ; Lin DL; Levan S; Nazareth M; Mahadevan U; Lynch SV
mBio; 2016 Aug; 7(4):. PubMed ID: 27531910
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiome diversity in acute severe colitis is distinct from mild to moderate ulcerative colitis.
Kedia S; Ghosh TS; Jain S; Desigamani A; Kumar A; Gupta V; Bopanna S; Yadav DP; Goyal S; Makharia G; Travis SPL; Das B; Ahuja V
J Gastroenterol Hepatol; 2021 Mar; 36(3):731-739. PubMed ID: 32870508
[TBL] [Abstract][Full Text] [Related]
39. Dysbiosis of the fecal microbiota in feedlot cattle with hemorrhagic diarrhea.
Zeineldin M; Aldridge B; Lowe J
Microb Pathog; 2018 Feb; 115():123-130. PubMed ID: 29275129
[TBL] [Abstract][Full Text] [Related]
40. Fecal microbiota transplantation for ulcerative colitis.
Matsuoka K
Immunol Med; 2021 Mar; 44(1):30-34. PubMed ID: 32663072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
